Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ocrelizumab plus methotrexate versus placebo plus methotrexate in active rheumatoid arthritis
2006-005147-28Phase 3Completed
- Sponsor
- Roche
- Start
- Feb 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Ocrelizumab + methotrexate with Placebo + methotrexate (2 arms). Primary endpoints: Efficacy on signs and symptoms of rheumatoid arthritis, Safety of ocrelizumab and 1 more. Started Feb 2007; status: completed.
02
Drugs
ocrelizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2006-005147-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005147-28.